Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets

v3.24.2.u1
Consolidated Balance Sheets - USD ($)
shares in Thousands
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Current assets        
Cash and cash equivalents $ 70,858,000 $ 82,585,000 $ 144,366,000  
Deposits Assets, Current 80,000,000 80,000,000    
Accounts Receivable, after Allowance for Credit Loss, Current 150,483,000 172,009,000    
Inventories 196,505,000 192,976,000    
Prepaid expenses 8,570,000 7,929,000    
Other current assets 17,575,000 24,596,000    
Total current assets 523,991,000 560,095,000    
Non-current assets        
Property, plant and equipment, net 187,189,000 197,552,000    
Goodwill 99,174,000 100,051,000    
Other intangible assets, net 116,461,000 127,781,000    
Operating lease right-of-use assets 17,928,000 18,895,000    
Long-term investments 121,755,000 115,083,000    
Other non-current assets 15,409,000 14,448,000    
Total non-current assets 557,916,000 573,810,000    
Total assets 1,081,907,000 1,133,905,000    
Current liabilities        
Accounts payable 49,495,000 46,785,000    
Accrued expenses and other current liabilities 31,627,000 36,656,000    
Employee related charges 26,666,000 33,877,000    
Deferred revenues - short-term 50,914,000 52,610,000    
Operating lease liabilities - short term 5,966,000 6,498,000    
Total current liabilities 164,668,000 176,426,000    
Non-current liabilities        
Deferred revenues - long-term 18,880,000 23,655,000    
Deferred income taxes 558,000 723,000    
Operating lease liabilities - long term 11,780,000 12,162,000    
Contingent consideration 11,851,000 11,900,000    
Other non-current liabilities 23,699,000 24,200,000    
Total non-current liabilities 66,768,000 72,640,000    
Total liabilities $ 231,436,000 249,066,000    
Commitments and Contingencies Disclosure [Abstract]        
Ordinary shares, authorized 180,000      
Equity        
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 shares; 67,086 shares and 65,677 shares issued and outstanding at December 31, 2022 and 2021, respectively $ 199,000 195,000    
Additional paid-in capital 3,111,057,000 3,091,649,000    
Accumulated other comprehensive loss (9,133,000) (7,079,000) $ (12,671,000) $ (12,818,000)
Accumulated deficit (2,251,652,000) (2,199,926,000)    
Total equity 850,471,000 884,839,000    
Total liabilities and equity $ 1,081,907,000 $ 1,133,905,000